Medline Inc.
MDLN· Nasdaq
MDLNMedline Inc.
Filed May 6, 2026 · 10-Q · 39 days after period end · 0002046386-26-000026
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $7.35B | $6.64B |
| Net Income | $239.00M | $319.00M |
| EPS Diluted | $0.16 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medline Inc. · CIK 2046386 · Engraved from SEC EDGAR
ended Mar 28, 2026 · filed May 6, 2026 · 39 d after period end
